Related references
Note: Only part of the references are listed.Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores
S. Y. Park et al.
INFECTION (2011)
Fibronectin-binding protein B variation in Staphylococcus aureus
Fiona M. Burke et al.
BMC MICROBIOLOGY (2010)
Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions
Alex J. McCarthy et al.
BMC MICROBIOLOGY (2010)
Safety and Immunogenicity of a Novel Staphylococcus aureus Vaccine: Results from the First Study of the Vaccine Dose Range in Humans
Clayton Harro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Induction of antibodies by Staphylococcus aureus nasal colonization in young children
N. J. Verkaik et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Novel targeted immunotherapy approaches for staphylococcal infection
Michael Otto
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Immunotherapeutic strategies to combat staphylococcal infections
Knut Ohlsen et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Towards the immune proteome of Staphylococcus aureus - The anti-S. aureus antibody response
Silva Holtfreter et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice
David Skurnik et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice
Hwan Keun Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Targeting of Alpha-Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model
Adam D. Kennedy et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Staphylococcal superantigen-like protein 10 (SSL10) binds to human immunoglobulin G (IgG) and inhibits complement activation via the classical pathway
Saotomo Itoh et al.
MOLECULAR IMMUNOLOGY (2010)
Preventing Surgical-Site Infections in Nasal Carriers of Staphylococcus aureus
Lonneke G. M. Bode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Proteomics uncovers extreme heterogeneity in the Staphylococcus aureus exoproteome due to genomic plasticity and variant gene regulation
Anne-Kathrin Ziebandt et al.
PROTEOMICS (2010)
Profiling the surfacome of Staphylococcus aureus
Annette Dreisbach et al.
PROTEOMICS (2010)
Phase 1/2 Double-Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study of Pagibaximab (BSYX-A110), an Antistaphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Bloodstream Infections, in Very-Low-Birth-Weight Neonates
Leonard E. Weisman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300
E. L. Brown et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Anti-Staphylococcus aureus immunotherapy: current status and prospects
Jorge Garcia-Lara et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Proteomics-Based Identification of Anchorless Cell Wall Proteins as Vaccine Candidates against Staphylococcus aureus
Eva Glowalla et al.
INFECTION AND IMMUNITY (2009)
Staphylococcal Vaccines and Immunotherapies
Adam C. Schaffer et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)
Reclassification of Staphylococcus aureus Nasal Carriage Types
Alex van Belkum et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Anti-Staphylococcal Humoral Immune Response in Persistent Nasal Carriers and Noncarriers of Staphylococcus aureus
Nelianne J. Verkaik et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Staphylococcus aureus: new evidence for intracellular persistence
Christian Garzoni et al.
TRENDS IN MICROBIOLOGY (2009)
Sequence diversity in the A domain of Staphylococcus aureus fibronectin-binding protein A
Anthony Loughman et al.
BMC MICROBIOLOGY (2008)
Vancomycin-resistant staphylococcus aureus in the United States, 2002-2006
Dawn M. Sievert et al.
CLINICAL INFECTIOUS DISEASES (2008)
Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphylococcus aureus in Mice
Lorena P. N. Tuchscherr et al.
INFECTION AND IMMUNITY (2008)
Vaccination and passive immunisation against Staphylococcus aureus
Adam C. Schaffer et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Vaccine protection against Staphylococcus aureus pneumonia
Juliane Bubeck Wardenburg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from ubclinical mastitis in dairy cattle
Byoung Sun Chang et al.
VACCINE (2008)
The Staphylococcus aureus Protein Sbi Acts as a Complement Inhibitor and Forms a Tripartite Complex with Host Complement Factor H and C3b
Katrin Haupt et al.
PLOS PATHOGENS (2008)
Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia
Mark E. Rupp et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005
Eili Klein et al.
EMERGING INFECTIOUS DISEASES (2007)
Invasive methicillin-resistant Staphylococcus aureus infections in the United States
R. Monina Klevens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Infection control by antibody disruption of bacterial quorum sensing signaling
Junguk Park et al.
CHEMISTRY & BIOLOGY (2007)
Staphylococcal complement evasion by various convertase-blocking molecules
Ilse Jongerius et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Clinical trial of safety and efficacy of IHN-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants
Mitchell Dejonge et al.
JOURNAL OF PEDIATRICS (2007)
Distribution of capsular and surface polysaccharide serotypes of Staphylococcus aureus
Christof von Eiff et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests
Isabelle Verdier et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Vaccine assembly from surface proteins of Staphylococcus aureus
Yukiko K. Stranger-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection
Dong-Liang Hu et al.
MICROBES AND INFECTION (2006)
Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
Steven J. Projan et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia
J. John Weems et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
An immunogenicity study of a newly fusion protein Cna-FnBP vaccinated against Staphylococcus aureus infections in a mice model
Hong Zhou et al.
VACCINE (2006)
A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin
D. K. Benjamin et al.
JOURNAL OF PERINATOLOGY (2006)
Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain:: A potential explanation for their improved prognosis in severe sepsis
S Holtfreter et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage
SR Clarke et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model
AC Schaffer et al.
INFECTION AND IMMUNITY (2006)
A novel Staphylococcus aureus vaccine:: Iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S-aureus sepsis model
NA Kuklin et al.
INFECTION AND IMMUNITY (2006)
The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on β-hemolysin-converting bacteriophages
WJB van Wamel et al.
JOURNAL OF BACTERIOLOGY (2006)
Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo
JH Vernachio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes
JA Lindsay et al.
JOURNAL OF BACTERIOLOGY (2006)
The role of nasal carriage in Staphylococcus aureus infections
HFL Wertheim et al.
LANCET INFECTIOUS DISEASES (2005)
Multicenter study to assess safety and efficacy of INH-A21 a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants
B Bloom et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly-N-acetyl-β-(1-6)-glucosamine
T Maira-Litrán et al.
INFECTION AND IMMUNITY (2005)
Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia
TP Lodise et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Anti-opsonic properties of staphylokinase
SHM Rooijakkers et al.
MICROBES AND INFECTION (2005)
The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-FcαRI binding and serum killing of bacteria
R Langley et al.
JOURNAL OF IMMUNOLOGY (2005)
Staphylococcus aureus types 5 and 8 capsular polysaccaride-protein conjugate vaccines
JB Robbins et al.
AMERICAN HEART JOURNAL (2004)
Development of StaphVAX™, a polysaccharide conjugate vaccine against S-aureus infection:: from the lab bench to phase III clinical trials
AI Fattom et al.
VACCINE (2004)
Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX®) in hemodialysis patients
A Fattom et al.
VACCINE (2004)
Clinical identifiers of complicated Staphylococcus aureus bacteremia
VG Fowler et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Autoinduction and signal transduction in the regulation of staphylococcal virulence
RP Novick
MOLECULAR MICROBIOLOGY (2003)
Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis
J Vernachio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination
RD LeClaire et al.
INFECTION AND IMMUNITY (2002)
Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.
H Shinefield et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant
E Josefsson et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
The significance of nasal carriage of Staphylococcus aureus as risk factor for human skin infections
K Toshkova et al.
FEMS MICROBIOLOGY LETTERS (2001)
Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat
A Rennermalm et al.
VACCINE (2001)
Nasal carriage as a source of Staphylococcus aureus bacteremia.
C von Eiff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis
EBH Hume et al.
INFECTION AND IMMUNITY (2000)
Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections
JP Burnie et al.
INFECTION AND IMMUNITY (2000)
Exotoxins of Staphylococcus aureus
MM Dinges et al.
CLINICAL MICROBIOLOGY REVIEWS (2000)
Share Paper
